Background: Human mesenchymal stem cells (hMSCs) hold promise for use in cell-based therapies and tissue engineering. Although hMSCs are thought to be stable ex vivo, it is possible that
also reproduced on the ground in human and animals and also modeled in cell-based analogs. With limited missions in space, experimental studies in these analogs have provided much
ceramic-based bone graft substitutes, (5) polymer-based bone graft substitutes, and (6) cell-based bone graft substitutes. The successful performance of bone graft substitutes depends on their ability
sensitize cancer cells lacking EGFR mutations to EGFR-targeted therapy. Using both in vitro cell-based assays and in vivo preclinical xenograft model systems, we demonstrated that combined inhibition
experiment, DNA aptamer mediated siRNA delivery with the same efficiency compared with lipofectamine2000. These cell-based aptamers are promising molecular probes for the diagnosis and treatment of GBM. Aptamers
aided design and synthesis of prolyl oligopeptidase inhibitors that demonstrated high inhibitory potency in cell-based assays and the experimental determination of their major metabolites initially predicted by IMPACTS
compounds from 6,735 medicinal plants. Then, the perfect hits were evaluated using the cell-based calcium assay. Finally, two compounds from Curcuma and Berberine were confirmed to be novel
ecent studies shown stem cell-based therapy can potentially improve the clinical outcome of Parkinson's disease (PD). However, issues concerning the purported efficiency of dopaminergic (DA) neuron generation
Multiple integration sites were also loaded in HAC/MAC. The recent emergence of stem cell-based tissue engineering has opened up new avenues for gene-and cell-therapies. Possible applications
cells) contribute to the post-ischemic neovascularization. Stem/progenitor cells have been used for cell-based therapy to promote revascularization after peripheral or myocardial ischemia. Excess amount of reactive…
Cell-based therapy is a promising biological approach for the treatment of cartilage defects. Due to the small size of autologous cartilage samples available for cell transplantation in patients, chondrocytes
using nonspecific intercalating dyes. To gain both sensitivity and specificity for cell-based analysis, bioassays, such as DNA amplification, needed to be incorporated into the LabReader. Further, sample preparation
ingredients and evaluation of concentrations effects are important for understanding their potential therapeutic applications. Cell-based assays using reporter/ indicator cells such as macrophages are commonly used as a…
Cell-based therapy is a promising therapy for myocardial infarction. Endogenous repair of the heart muscle after myocardial infarction is a challenge because adult cardiomyocytes have a limited capacity
implications of the proposed extensions for bone marrow impairments, suggesting a hematopoietic stem cell-based model according to which environmental factors plausibly add an extra degree of complexity
progenitor cells with adequate neurogenic potential has been the major setback in developing effective cell-based therapies against a wide range of neurological disorders. Derivation of human embryonic stem cells
rapid assembly and optimization of multigene constructs. For gene therapy or for creating cell-based model systems multiple genes might have to be introduced and at the same time
been successfully isolated from various tissues and are currently utilized for tissue-engineering and cell-based therapies. Traditionally, hMSCs have been isolated from bone marrow, but the number of cells
clinical responses unfortunately remain poor. We have examined the potential of developing more effective cell-based gene therapies for preventing prostate cancer progression, using adipose-derived mesenchymal stem cells
Background: Stem cell-based therapy as a promising alternative approach to cure liver diseases is currently a focus of research worldwide. So far, preliminary studies of liver stem cell therapy
maintenance and lung injury suppression of therapeutic research instead. Stem/progenitor cell therapy and cell-based gene therapy are currently under investigation for their potential therapeutic effects
tendinopathy and overuse tendinitis. Novel therapies aim to restore tendon functionality by means of cell-based therapy, growth factor delivery and tissue engineering approaches. This study examined
Purpose: Current arterial tissue engineering research focuses on cell-based approaches. The purpose of this study is to investigate the potential of mammalian host to remodel synthetic polymeric grafts into
MSCs will require expansion in vitro to provide sufficient functional biological material for a cell-based therapy. Currently, most stem cell culture processes are conducted at laboratory bench scale
reorganization by histone acetylation and ALP activity, we have developed a novel and efficient cell-based screening assay using MSCs and identified bioactive small molecules after isolation from natural product
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.